Chee Keong Yap
CIK: 0001994541
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
BGLC
BioNexus Gene Lab Corp
Director
Discretionary Trading P&L
Holdings
About Yap Chee Keong
Yap Chee Keong (SEC CIK 0001994541) files insider reports with the SEC as Director of BioNexus Gene Lab Corp (BGLC).
Signal8 holds 1 ownership filing by Yap Chee Keong, a Form 4, filed on Aug 14, 2026. Those filings report 1 transaction, the latest on Aug 13, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Yap Chee Keong's filings is in KUALA LUMPUR.
Recent filings by Yap Chee Keong
- Aug 13, 2026: Grant or award of BGLC shares (Form 4, code A).
Other insiders filing for BioNexus Gene Lab Corp (BGLC)
- Tan Lee Su-Leng, Chief Executive Officer
- Bin Abdul Hamid Muhammad Azrul, Director
- Chong Set Fui, Chief Financial Officer
- Low Jook Yuen, Director
- FIDELION DIAGNOSTICS PTE. LTD., Officer